Stereotactic Radiation Therapy (SRT) is used to treat cancers using substantially higher doses of radiation than conventional radiotherapy, while limiting the dose of radiation to nearby normal tissues. SRT is commonly employed in cancers of the lung, liver, and pancreas, where it is used to shrink tumours that have spread to other parts of the body.
Sunitinib (Sutent®) has been a standard of care treatment for kidney cancer since 2006 and works by blocking a molecule called VEGFR to prevent cancerous tumours from growing new blood vessels.
The purpose of this trial is to explore the safety and effectiveness of SRT for the treatment of kidney cancer among patients already being treated with Sunitinib (Sutent®).
Specifically, this trial will investigate how much longer patients receiving SRT are able to continue receiving Sunitinib before they must switch to a different medication.
- Clear cell kidney cancer
- Receiving Sunitinib for at least 3 months prior to enrollment
- No more than 5 tumours may be treated with SRT
Additional eligibility criteria will apply. Please speak to your doctor.
Find out more about this study.
|Hospital / Cancer Centre||Principal Investigator||Location||Trial Status|
|Hospital / Cancer CentreBC Cancer Agency||Principal InvestigatorDr Christian Kollmannsberger||LocationVancouver, BC||Trial StatusRecruiting|
|Hospital / Cancer CentreTom Baker Cancer Centre||Principal InvestigatorDr Gerald Lim||LocationCalgary, AB||Trial StatusRecruiting|
|Hospital / Cancer CentreCross Cancer Institute||Principal InvestigatorDr Samir Patel||LocationEdmonton, AB||Trial StatusRecruiting|
|Hospital / Cancer CentreCancerCare Manitoba||Principal InvestigatorDr Arbind Dubey||LocationWinnipeg, MB||Trial StatusRecruiting|
|Hospital / Cancer CentreJuravinski Cancer Centre | Hamilton Health Sciences Centre||Principal InvestigatorDr Anand Swaminath||LocationHamilton, ON||Trial StatusRecruiting|
|Hospital / Cancer CentreLondon Health Sciences Centre||Principal InvestigatorDr Belal Ahmad||LocationLondon, ON||Trial StatusRecruiting|
|Hospital / Cancer CentreOttawa Hospital Cancer Centre||Principal InvestigatorDr Scott Morgan||LocationOttawa, ON||Trial StatusRecruiting|
|Hospital / Cancer CentreOdette Cancer Centre | Sunnybrook Health Sciences Centre||Principal InvestigatorDr Georg Bjarnason & Dr Patrick Cheung||LocationToronto, ON||Trial StatusRecruiting|
|Hospital / Cancer CentrePrincess Margaret Cancer Centre | University Health Network||Principal InvestigatorDr Srikala Sridhar||LocationToronto, ON||Trial StatusRecruiting|
|Hospital / Cancer CentreHôpital général juif | Jewish General Hospital||Principal InvestigatorDr Tamim Niazi||LocationMontréal, QC||Trial StatusRecruiting|
|Hospital / Cancer CentreCentre universitaire de santé McGill | McGill University Health Centre||Principal InvestigatorDr Fabio Cury||LocationMontréal, QC||Trial StatusRecruiting|
|Hospital / Cancer CentreQEII Health Sciences Centre||Principal InvestigatorDr Lori Wood||LocationHalifax, NS||Trial StatusRecruiting|